Abstract

AbstractBackgroundObstructive sleep apnea (OSA), characterized by sleep fragmentation and chronic intermittent hypoxia (CIH), is a risk factor for Alzheimer’s disease (AD) development and progression. Recent epidemiological studies point to CIH as the best predictor of developing cognitive decline and AD in elderly with OSA. However, the precise underlying mechanism(s) remain unknown. Tau pathology, a major neuropathological hallmark of the disease, is known to be correlated with cognitive impairment in AD. Further, increase in tau pathology has been linked to CIH suggesting that CIH may mediate AD risk through tau pathology. The present study was undertaken to evaluate the effect of CIH on human tau seeding and propagation, and to further investigate the effects of CIH on cognition, synaptic plasticity, neuronal network excitability, and gene expression profiles in a human mutant tau mouse model of AD and related tauopathies (P301S mice).MethodWe exposed 4‐4.5‐month‐old, male, mutant human tau P301S/WT mice to an 8‐week CIH protocol simulating human OSA (6 m cycle: 21% O2 to 8% O2 to 21% O2, 80 cycles per 8 h during daytime), and assessed its effect on tau seeding and spread and on various AD‐related phenotypic and molecular signatures. Age‐ and gender‐ matched P301S/WT mice were reared in normoxia (21% O2) as experimental controls.ResultExperimentally induced CIH significantly enhanced human tau seeding and spread across connected neuroanatomical circuitry in the brains of a P301S mutant human tau model of AD; also, it increased phospho‐tau load in P301S mice. CIH also exacerbated memory deficit and synaptic plasticity impairment and increased disinhibition‐like behavior in P301S mice. However, CIH had no effect on seizure susceptibility and network hyperexcitability in these mice. Finally, CIH exacerbated AD‐related pathogenic molecular signaling in P301S mice.ConclusionIn a comprehensive panel of immunohistochemical, behavioral, biochemical, electrophysiological, and transcriptomic analyses, we found that CIH enhances human tau seeding and spread, and exacerbates tau pathology, cognitive deficit, disinhibition‐like behavior, short‐ and long‐term synaptic plasticity impairment, and AD‐related molecular signaling in P301S mouse model of AD and related tauopathies. These data provide a mechanistic basis of a role for CIH and OSA in AD pathogenesis.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.